این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
چهارشنبه 29 بهمن 1404
International Journal of Hematology-Oncology and Stem Cell Research
، جلد ۹، شماره ۳، صفحات ۱۳۳-۱۳۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Hairy cell leukemia: A retrospective study on 11 patients in the Western of Iran.
چکیده انگلیسی مقاله
Background: Hairy cell leukemia (HCL) is a chronic B-cell lymphoid leukemia characterized by pancytopenia, splenomegaly, myelofibrosis and the presence in peripheral blood, bone marrow and spleen of atypical lymphoid cells with a hairy aspect. The study aims to evaluate a group of patients with hairy cell leukemia, hospitalized in the Clinic of Hematology and Oncology, Kermanshah, Iran, on a period of 15 years and affect of between cladribine therapy and IFN therapy on the patients with HCL. Methods: This is a retrospective analysis of 11 patients in the Clinic of Hematology and Oncology, Kermanshah, Iran, between 2004 and 2013. Clinical features at diagnosis, differential count (platelet, Hb and WBC) types of therapy, survival rate and BRAF mutation have been monitored. As a result, cladribine therapy is the best treatment option for patients. Results: The mean age of patients was 50 years with 100% of men. Approximately 45% of them had splenomegaly at diagnosis. 100% of patients had pancytopenia at diagnosis.9% of patients had mutation of BRAF V600E. Before of treatment, there were fatigue, weight loss, vomiting, fever, night sweat and itching in all of the patients. Conclusion: There is presence of hairy cells in peripheral blood and bone marrow and was associated with pancytopenia, splenomegaly, myelofibrosis in HCL patients. Also, cladribine therapy is best option for treatment of patients and it is better than IFN.
کلیدواژههای انگلیسی مقاله
Cladribine,y Cell Leukemia,Splenomegaly
نویسندگان مقاله
مهرداد پاینده | mehrdad payandeh
department of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی کرمانشاه (Kermanshah university of medical sciences)
مسعود صادقی | masoud sadeghi
students research committee, kermanshah university of medical sciences, kermanshah, iran ; medical biology research center, kermanshah university of medical sciences, kermanshah, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی کرمانشاه (Kermanshah university of medical sciences)
ادریس صادقی | edris sadeghi
students research committee, kermanshah university of medical sciences, kermanshah, iran ; medical biology research center, kermanshah university of medical sciences, kermanshah, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی کرمانشاه (Kermanshah university of medical sciences)
نشانی اینترنتی
http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/382
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Articles
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات